{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:36:11Z","timestamp":1777624571515,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Australian Government Research Training Program Scholarship"},{"name":"Australian National Health and Medical Research Council Investigator Grants"},{"name":"Australian Medical Research Future Fund Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42695-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:47:10Z","timestamp":1773697630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating southern pigtail macaques as an immunological model for human antibody responses"],"prefix":"10.1038","volume":"16","author":[{"given":"Veronica P.","family":"Zoest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Shi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Esterbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Juno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"42695_CR1","first-page":"14055","volume":"1","author":"H-P Kiem","year":"2014","unstructured":"Kiem, H.-P. et al. Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies. Mol. Ther. 1, 14055 (2014).","journal-title":"Mol. Ther."},{"key":"42695_CR2","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41598-019-41506-5","volume":"9","author":"M Khanna","year":"2019","unstructured":"Khanna, M. et al. Mucosal and systemic SIV-specific cytotoxic CD4+ T cell hierarchy in protection following intranasal\/intramuscular recombinant pox-viral vaccination of pigtail macaques. Sci. Rep. 9, 5661 (2019).","journal-title":"Sci. Rep."},{"key":"42695_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41541-025-01221-x","volume":"10","author":"M Nakayama","year":"2025","unstructured":"Nakayama, M. et al. Long-term efficacy of an inactivated H5N1 whole-particle influenza vaccine in nonhuman primates. NPJ. Vaccines 10, 164 (2025).","journal-title":"NPJ. Vaccines"},{"key":"42695_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41541-024-00980-3","volume":"9","author":"T Hauguel","year":"2024","unstructured":"Hauguel, T. et al. Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines. NPJ. Vaccines 9, 183 (2024).","journal-title":"NPJ. Vaccines"},{"key":"42695_CR5","doi-asserted-by":"publisher","first-page":"1108420","DOI":"10.3389\/fviro.2023.1108420","volume":"3","author":"J Tisoncik-Go","year":"2023","unstructured":"Tisoncik-Go, J. et al. Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in Macaca nemestrina. Front. Virol. 3, 1108420 (2023).","journal-title":"Front. Virol."},{"key":"42695_CR6","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1016\/j.vaccine.2013.10.041","volume":"31","author":"Y Vanloubbeeck","year":"2013","unstructured":"Vanloubbeeck, Y. et al. Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques. Vaccine 31, 6216\u20136224 (2013).","journal-title":"Vaccine"},{"key":"42695_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41541-023-00656-4","volume":"8","author":"B Bollman","year":"2023","unstructured":"Bollman, B. et al. An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection. NPJ. Vaccines 8, 58 (2023).","journal-title":"NPJ. Vaccines"},{"key":"42695_CR8","doi-asserted-by":"publisher","first-page":"7892","DOI":"10.1016\/j.vaccine.2020.10.064","volume":"38","author":"M Guebre-Xabier","year":"2020","unstructured":"Guebre-Xabier, M. et al. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine 38, 7892\u20137896 (2020).","journal-title":"Vaccine"},{"key":"42695_CR9","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/s41590-021-01021-0","volume":"22","author":"KS Corbett","year":"2021","unstructured":"Corbett, K. S. et al. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nat. Immunol. 22, 1306\u20131315 (2021).","journal-title":"Nat. Immunol."},{"key":"42695_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran, W. F. et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell 184, 476\u2013488.e11 (2021).","journal-title":"Cell"},{"key":"42695_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.abc6284","volume":"369","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science 369, 806\u2013811 (2020).","journal-title":"Science"},{"key":"42695_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","volume":"30","author":"S Black","year":"2011","unstructured":"Black, S. et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr. Infect. Dis. J. 30, 1081\u20131085 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"42695_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","volume":"162","author":"RT Chen","year":"1990","unstructured":"Chen, R. T. et al. Measles antibody: Reevaluation of protective titers. J. Infect. Dis. 162, 1036\u20131042 (1990).","journal-title":"J. Infect. Dis."},{"key":"42695_CR14","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1172\/JCI41902","volume":"120","author":"D Corti","year":"2010","unstructured":"Corti, D. et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120, 1663\u20131673 (2010).","journal-title":"J. Clin. Invest."},{"key":"42695_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.chom.2018.05.001","volume":"23","author":"I Setliff","year":"2018","unstructured":"Setliff, I. et al. Multi-donor longitudinal antibody repertoire sequencing reveals the existence of public antibody clonotypes in HIV-1 infection. Cell Host Microbe 23, 845\u2013854.e6 (2018).","journal-title":"Cell Host Microbe"},{"key":"42695_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","volume":"182","author":"CO Barnes","year":"2020","unstructured":"Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 182, 828\u2013842 (2020).","journal-title":"Cell"},{"key":"42695_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"42695_CR18","doi-asserted-by":"publisher","first-page":"109822","DOI":"10.1016\/j.celrep.2021.109822","volume":"37","author":"AK Wheatley","year":"2021","unstructured":"Wheatley, A. K. et al. Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain. Cell Rep 37, 109822 (2021).","journal-title":"Cell Rep"},{"key":"42695_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1126\/science.1139247","volume":"316","author":"RA Gibbs","year":"2007","unstructured":"Gibbs, R. A. et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 316, 222\u2013234 (2007).","journal-title":"Science"},{"key":"42695_CR20","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3389\/fimmu.2017.01407","volume":"8","author":"A Ramesh","year":"2017","unstructured":"Ramesh, A. et al. Structure and diversity of the rhesus macaque immunoglobulin loci through multiple de novo genome assemblies. Front. Immunol. 8, 1407 (2017).","journal-title":"Front. Immunol."},{"key":"42695_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00251-016-0921-2","volume":"68","author":"G-Y Yu","year":"2016","unstructured":"Yu, G.-Y. et al. Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description. Immunogenetics 68, 417\u2013428 (2016).","journal-title":"Immunogenetics"},{"key":"42695_CR22","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-021-03451-0","volume":"592","author":"A Rhie","year":"2021","unstructured":"Rhie, A. et al. Towards complete and error-free genome assemblies of all vertebrate species. Nature 592, 737\u2013746 (2021).","journal-title":"Nature"},{"key":"42695_CR23","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M.-P. & Giudicelli, V. IMGT\/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013W508 (2008).","journal-title":"Nucleic Acids Res."},{"key":"42695_CR24","first-page":"695","volume":"6","author":"V Giudicelli","year":"2011","unstructured":"Giudicelli, V., Brochet, X. & Lefranc, M.-P. IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb. Protoc. 6, 695\u2013715 (2011).","journal-title":"Cold Spring Harb. Protoc."},{"key":"42695_CR25","doi-asserted-by":"crossref","unstructured":"Ye, J., Ma, N., Madden, T. & Ostell, J. IgBLAST: An immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34\u2013W40 (2013).","DOI":"10.1093\/nar\/gkt382"},{"key":"42695_CR26","doi-asserted-by":"crossref","unstructured":"Shi, R. et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584, 120\u2013124 (2020).","DOI":"10.1038\/s41586-020-2381-y"},{"key":"42695_CR27","doi-asserted-by":"crossref","unstructured":"Zost, S. J. et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature 584, 443\u2013449 (2020).","DOI":"10.1038\/s41586-020-2548-6"},{"key":"42695_CR28","doi-asserted-by":"crossref","unstructured":"Kitaura, K. et al. Different Somatic Hypermutation Levels among Antibody Subclasses Disclosed by a New Next-Generation Sequencing-Based Antibody Repertoire Analysis. Front. Immunol. 8, 389 (2017).","DOI":"10.3389\/fimmu.2017.00389"},{"key":"42695_CR29","doi-asserted-by":"crossref","unstructured":"Kaduk, M., Corcoran, M. & Karlsson Hedestam, G. B. Addressing IGHV Gene Structural Diversity Enhances Immunoglobulin Repertoire Analysis: Lessons From Rhesus Macaque. Front. Immunol. 13, 818440 (2022).","DOI":"10.3389\/fimmu.2022.818440"},{"key":"42695_CR30","doi-asserted-by":"crossref","unstructured":"Barnes, C. O. et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 588, 682\u2013687 (2020).","DOI":"10.1038\/s41586-020-2852-1"},{"key":"42695_CR31","doi-asserted-by":"crossref","unstructured":"Yuan, M. et al. Structural basis of a shared antibody response to SARS-CoV-2. Science 369, 1119\u20131123 (2020).","DOI":"10.1126\/science.abd2321"},{"key":"42695_CR32","doi-asserted-by":"crossref","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","DOI":"10.1038\/s41586-020-2349-y"},{"key":"42695_CR33","unstructured":"Westendorf, K. et al. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants. Cell Rep 39, 110812 (2022)."},{"key":"42695_CR34","doi-asserted-by":"crossref","unstructured":"Manso, T. et al. IMGT\u00ae databases, related tools and web resources through three main axes of research and development. Nucleic Acids Res. 50, D1262\u2013D1272 (2022).","DOI":"10.1093\/nar\/gkab1136"},{"key":"42695_CR35","doi-asserted-by":"crossref","unstructured":"Guo, Y., Waltari, E., Lu, H., Sheng, Z. & Wu, X. Novel rhesus macaque immunoglobulin germline genes identified by three sequencing approaches. Front. Immunol. 15, 1506348 (2024).","DOI":"10.3389\/fimmu.2024.1506348"},{"key":"42695_CR36","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez Bernat, N. et al. Rhesus and cynomolgus macaque immunoglobulin heavy-chain genotyping yields comprehensive databases of germline VDJ alleles. Immunity 54, 355\u2013366.e4 (2021).","DOI":"10.1016\/j.immuni.2020.12.018"},{"key":"42695_CR37","doi-asserted-by":"crossref","unstructured":"Pushparaj, P. et al. Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses. Front. Virol. 3, 1128253 (2023).","DOI":"10.3389\/fviro.2023.1128253"},{"key":"42695_CR38","doi-asserted-by":"crossref","unstructured":"Skinner, N. E. et al. Convergent antibody responses are associated with broad neutralization of Hepatitis C virus. Front. Immunol. 14, 1135841 (2023).","DOI":"10.3389\/fimmu.2023.1135841"},{"key":"42695_CR39","doi-asserted-by":"crossref","unstructured":"Ehrhardt, S. A. et al. Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV. Nat. Med. 25, 1589\u20131600 (2019).","DOI":"10.1038\/s41591-019-0602-4"},{"key":"42695_CR40","doi-asserted-by":"crossref","unstructured":"Sangesland, M. et al. Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaques. Sci. Transl. Med. 17, eady3570 (2025).","DOI":"10.1126\/scitranslmed.ady3570"},{"key":"42695_CR41","doi-asserted-by":"crossref","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved Influenza Virus epitope. Science 324, 246\u2013251 (2009).","DOI":"10.1126\/science.1171491"},{"key":"42695_CR42","doi-asserted-by":"crossref","unstructured":"Chen, F. et al. Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins. Immunity 54, 781\u2013796.e4 (2021).","DOI":"10.1016\/j.immuni.2021.02.013"},{"key":"42695_CR43","doi-asserted-by":"crossref","unstructured":"Dejnirattisai, W. et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell 184, 2183\u20132200.e22 (2021).","DOI":"10.1016\/j.cell.2021.02.032"},{"key":"42695_CR44","doi-asserted-by":"crossref","unstructured":"Zhang, Q. et al. Potent and protective IGHV3-53\/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. Nat. Commun. 12, 4210 (2021).","DOI":"10.1038\/s41467-021-24514-w"},{"key":"42695_CR45","doi-asserted-by":"crossref","unstructured":"Greaney, A. J. et al. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Sci. Transl. Med. 13, eabi9915 (2021).","DOI":"10.1126\/scitranslmed.abi9915"},{"key":"42695_CR46","doi-asserted-by":"crossref","unstructured":"Tan, H.-X. et al. Adaptive immunity to human coronaviruses is widespread but low in magnitude. Clin. Transl. Immunology 10, e1264 (2021).","DOI":"10.1002\/cti2.1264"},{"key":"42695_CR47","doi-asserted-by":"crossref","unstructured":"Baldrick, P., Richardson, D., Elliott, G. & Wheeler, A. W. Safety evaluation of Monophosphoryl Lipid A (MPL): An immunostimulatory adjuvant. Regul. Toxicol. Pharmacol. 35, 398\u2013413 (2002).","DOI":"10.1006\/rtph.2002.1541"},{"key":"42695_CR48","doi-asserted-by":"crossref","unstructured":"Tan, H.-X. et al. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat. Commun. 12, 1403 (2021).","DOI":"10.1038\/s41467-021-21665-8"},{"key":"42695_CR49","doi-asserted-by":"crossref","unstructured":"Juno, J. A. et al. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat. Med. 26, 1428 (2020).","DOI":"10.1038\/s41591-020-0995-0"},{"key":"42695_CR50","doi-asserted-by":"crossref","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","DOI":"10.1126\/science.abb2507"},{"key":"42695_CR51","doi-asserted-by":"crossref","unstructured":"Lee, W. S. et al. Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection. Sci. Adv. 9, eadg5301 (2023).","DOI":"10.1126\/sciadv.adg5301"},{"key":"42695_CR52","doi-asserted-by":"crossref","unstructured":"Tea, F. et al. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants. PLoS Med. 18, e1003656 (2021).","DOI":"10.1371\/journal.pmed.1003656"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42695-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42695-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42695-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:31:00Z","timestamp":1777419060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42695-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42695"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42695-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13710"}}